US Market Entry US regulatory approval and reimbursement readiness are critical levers; collaborate on regulatory strategy, clinical data generation, and hospital procurement to accelerate Phoenix adoption once investigations conclude.

European Channel Europe-approved Phoenix enables immediate channel expansion through regional distributors and hospital systems; partner with established medical device distributors to reach peripheral endovascular centers efficiently.

Competitive Gap Position a differentiated value proposition emphasizing procedural efficiency and cost per procedure, backed by early clinical data; align with endovascular centers seeking alternatives to incumbent devices.

Training & Education Offer comprehensive training programs, simulation labs, and clinical education packages to drive adoption among surgeons and OR staff, building readiness for future US market entry.

Clinical Evidence Develop and leverage clinical evidence through registries or pivotal studies to support reimbursement and market access in both EU and US regions.